Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Imatinib on Dasatinib Pharmacokinetics in Healthy Volunteers
NCT02129166Phase 1Withdrawn
- Sponsor
- University of Florida
- Start
- Sep 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of imatinib in leukemia (2 arms), sponsored by University of Florida. Primary endpoint: Area under the plasma concentration versus time curve at 24 hours. Planned start Sep 2014; status: withdrawn.
02
Drugs
03
Conditions
leukemia
Beyond the preview
Go deeper on NCT02129166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02129166.